We are live on ! Find out more
ZURA icon

Zura Bio

36 hedge funds and large institutions have $59M invested in Zura Bio in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

6% more funds holding

Funds holding: 3436 (+2)

2% more capital invested

Capital invested by funds: $58.1M → $59M (+$946K)

50% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 6

Holders
36
Holders Change
+2
Holders Change %
+5.88%
% of All Funds
0.61%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
3
Reduced
6
Closed
4
Calls
$171K
Puts
Net Calls
+$171K
Net Calls Change
-$12K

ZURA Hedge Fund Activity: Q2 2022 in Review

36 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Zura Bio (ZURA) for Q2 2022, worth a combined $59M — up 1.6% from $58.1M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new ZURA positions and 4 closed out — a net gain of 2 holders — while 3 added to existing stakes and 6 trimmed.

The largest buyer was Magnetar Financial, opening a new position worth an estimated $11.7M. The largest seller was Basso Capital Management, cutting an estimated $1.01M.

  • 36 institutional investors held Zura Bio (ZURA) as of Q2 2022, up from 34 in Q1 2022.
  • Funds reported $59M of Zura Bio stock for Q2 2022, up 1.6% quarter-over-quarter.
  • 6 funds opened new Zura Bio positions in Q2 2022 and 4 closed out, a net change of +2 holders.
  • The largest Zura Bio buyer in Q2 2022 was Magnetar Financial, an estimated $11.7M added.
  • The largest Zura Bio seller in Q2 2022 was Basso Capital Management, an estimated $1.01M sold.

Based on aggregated 13F filings for Q2 2022.